{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:00:48Z","timestamp":1775790048678,"version":"3.50.1"},"reference-count":13,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T00:00:00Z","timestamp":1331596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Tuberculosis is a global health problem. The Mycobacterium bovis Bacille Calmette Guerin (BCG) vaccine has variable efficacy (0\u201380%) so there is a drive to develop novel vaccines. The cytokine, interferon gamma (IFN\u03b3), is an essential component of the protective response to M. tuberculosis (M. tb) infection and is also produced in response to BCG vaccination. Induction of an IFN\u03b3 response is used as a biomarker of successful vaccination in the assessment of new tuberculosis (TB) vaccines. The IFN\u03b3 ELISPOT assay provides an important tool for TB research. It is used for both the diagnosis of infection (T.Spot assay), and for the evaluation of the immunogenicity of new TB vaccine candidates in human clinical trials, in the non-human primate (NHP) model of TB infection studies. The ELISPOT assay captures IFN\u03b3 produced by peripheral blood mononuclear cells (PBMCs) following specific stimulation, onto a membrane so individual cells can be enumerated and the frequency of responding cells determined. Hence spot forming units (SFU) per 106 cells provide the traditional measure for ELISPOT assays. The discriminatory power of SFU is limited. In some situations, the number of SFU in BCG vaccinated, and unvaccinated, subjects was found to be similar, although the spots were observed to be larger in vaccinated subjects. Spot size potentially provides a measure of the quantity of cytokine produced by individual cells. The AID ELISPOT plate reader software used to determine frequency of spots also has the capability to determine the size of each spot. Consideration of spot size in combination with spot forming units was investigated in our studies of BCG immunogenicity. This additional readout was found to enhance the discriminatory power of the ELISPOT assay, and provide more information on the immune response to BCG vaccination and infection with M.tb.<\/jats:p>","DOI":"10.3390\/cells1010005","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T13:15:25Z","timestamp":1331644525000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis"],"prefix":"10.3390","volume":"1","author":[{"given":"Laura S.","family":"Sibley","sequence":"first","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"White","sequence":"additional","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Marriott","sequence":"additional","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Dennis","sequence":"additional","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Marsh","sequence":"additional","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally A.","family":"Sharpe","sequence":"additional","affiliation":[{"name":"Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"ref_1","unstructured":"(2011). Tuberculosis Facts."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(06)68383-9","article-title":"Tuberculosis in sub-Saharan Africa: Opportunities, challenges, and change in the era of antiretroviral treatment","volume":"367","author":"Corbett","year":"2006","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.prrv.2007.04.009","article-title":"Childhood tuberculosis: Old and new vaccines","volume":"8","author":"Hussey","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0163-4453(99)90002-6","article-title":"Genetic susceptibility to tuberculosis","volume":"39","author":"Newport","year":"1999","journal-title":"J. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00079-10","article-title":"Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing","volume":"17","author":"Sharpe","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","article-title":"Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis","volume":"70","author":"Vordermeier","year":"2002","journal-title":"Infect. Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JCM.02403-07","article-title":"Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis","volume":"46","author":"Chee","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tube.2008.06.005","article-title":"A Comparison of IFN\u03b3 detection methods used in tuberculosis vaccine trials","volume":"88","author":"Beveridge","year":"2008","journal-title":"Tuberculosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.tube.2009.09.002","article-title":"Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis","volume":"89","author":"Sharpe","year":"2009","journal-title":"Tuberculosis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1365-2249.2003.02209.x","article-title":"Immune biology of macaque lymphocyte populations during mycobacterial infection","volume":"133","author":"Lai","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cellimm.2009.04.002","article-title":"Increased per cell IFN-\u03b3 productivity indicates recent in vivo activation of T cells","volume":"258","author":"Schlingmann","year":"2009","journal-title":"Cell Immunol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/1\/1\/5\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:21Z","timestamp":1760219361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/1\/1\/5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,13]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,3]]}},"alternative-id":["cells1010005"],"URL":"https:\/\/doi.org\/10.3390\/cells1010005","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,13]]}}}